These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2937533)

  • 1. Ethinyl estradiol and medroxyprogesterone acetate in patients with epithelial ovarian carcinoma: a phase II study.
    Freedman RS; Saul PB; Edwards CL; Jolles CJ; Gershenson DM; Jones LA; Atkinson EN; Dana WJ
    Cancer Treat Rep; 1986 Mar; 70(3):369-73. PubMed ID: 2937533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined chemo- and hormone-therapy in advanced ovarian carcinoma--theoretical, experimental foundations and clinical results].
    Sevelda P
    Wien Klin Wochenschr Suppl; 1990; 183():3-29. PubMed ID: 2145702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequentially administered ethinyl estradiol and medroxyprogesterone acetate in the treatment of refractory epithelial ovarian carcinoma in patients with positive estrogen receptors.
    Fromm GL; Freedman RS; Fritsche HA; Atkinson EN; Scott W
    Cancer; 1991 Nov; 68(9):1885-9. PubMed ID: 1833046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethinyl estradiol and medroxyprogesterone treatment in advanced breast cancer: a pilot study.
    Pellegrini A; Massidda B; Mascia V; Ionta MT; Lippi MG; Muggiano A; Carboni E; Robustelli della Cuna G; Bernardo G; Strada MR; Pavesi L
    Cancer Treat Rep; 1981; 65(1-2):135-6. PubMed ID: 7226163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The protective effect of medroxyprogesterone acetate in patients with ovarian cancer treated with chemotherapy].
    Enzelsberger H; Sevelda P; Salzer H
    Gynakol Rundsch; 1988; 28 Suppl 2():195-7. PubMed ID: 2976722
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.
    Zanardi S; De Menech R; Pino G; Guarneri D; Dandolo G; Sanguineti M; Moro MG; Barbi GP; Paganuzzi M; Boccardo F
    Chemioterapia; 1985 Jun; 4(3):239-42. PubMed ID: 3161642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormonotherapy of metastatic breast cancer with tamoxifen and medroxyprogesterone acetate. Randomized trial comparing alternating sequences with successive applications].
    Mauriac L; Durand M; Bonichon F; Chauvergne J
    Bull Cancer; 1986; 73(2):148-54. PubMed ID: 2942203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose medroxyprogesterone acetate (MPA) in advanced chemotherapy-resistant ovarian carcinoma: a phase II study.
    Aabo K; Pedersen AG; Haid I; Dombernowsky P
    Cancer Treat Rep; 1982 Feb; 66(2):407-8. PubMed ID: 6459846
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of advanced endometrial adenocarcinoma with cyclic sequential ethinyl estradiol and medroxyprogesterone acetate.
    Tatman JL; Freedman RS; Scott W; Atkinson EN
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1619-21. PubMed ID: 2531671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined chemo-hormone therapy in advanced ovarian cancer. Results of the 2d Austrian ovarian cancer study].
    Sevelda P
    Gynakol Rundsch; 1990; 30 Suppl 1():57-61. PubMed ID: 2150399
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
    Giralt E; Jouve M; Palangie T; Bretaudeau B; Asselain B; Magdelenat H; Merle S; Zajdela A; Pouillart P
    Bull Cancer; 1984; 71(1):22-9. PubMed ID: 6324934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ethynyloestradiol and medroxyprogesterone acetate on the in vivo uptake and metabolism of 3H-oestradiol by breast tumour tissue in postmenopausal women.
    Reed MJ; Beranek PA; Bonney RC; Ghilchik MW; James VH
    Anticancer Res; 1987; 7(6):1265-9. PubMed ID: 2831795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.
    Covens A; Blessing J; Bender D; Mannel R; Morgan M;
    Gynecol Oncol; 2006 Mar; 100(3):586-90. PubMed ID: 16249022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of medroxyprogesterone acetate on side effects of CAP therapy in gynecological malignant tumors].
    Yanagawa Y; Okazaki T; Okamura S; Ueki M; Sugimoto O
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2393-8. PubMed ID: 2526618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group.
    Sikic BI; Scudder SA; Ballon SC; Soriero OM; Christman JE; Suey L; Ehsan MN; Brandt AE; Evans TL
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):26-32. PubMed ID: 3099393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
    Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors].
    Nomura Y; Tashiro H; Hisamatsu K; Toi M
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):513-8. PubMed ID: 2964811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of paclitaxel plus megestrol acetate in patients with paclitaxel-refractory ovarian cancer.
    Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
    Clin Cancer Res; 2000 Nov; 6(11):4201-4. PubMed ID: 11106232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial hyperplasia: a prospective randomized study of histopathology, tissue steroid receptors and plasma steroids after abrasio, with or without high dose gestagen treatment.
    Lindahl B; Alm P; Fernö M; Norgren A
    Anticancer Res; 1990; 10(3):725-30. PubMed ID: 2142394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.